WallStreetZenWallStreetZen

NYSE: AMAM
Ambrx Biopharma Inc Stock

$1.80-0.05 (-2.7%)
Updated Feb 3, 2023
AMAM Price
$1.80
Fair Value Price
N/A
Market Cap
$69.58M
52 Week Low
$0.38
52 Week High
$5.12
P/E
0.27x
P/B
0.49x
P/S
19.54x
PEG
N/A
Dividend Yield
N/A
Revenue
$5.24M
Earnings
-$90.56M
Gross Margin
100%
Operating Margin
-1,678.64%
Profit Margin
-1,729.9%
Debt to Equity
0.28
Operating Cash Flow
-$68M
Beta
-0.61
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

AMAM Overview

Ambrx Biopharma Inc. is a clinical-stage company developing engineered precision biologics using its proprietary expanded genetic code technology platform. It creates antibody-drug conjugate and immune-oncology conjugate candidates, including ARX788, ARX517, ARX305, and ARX822. Ambrx collaborates with multiple pharmaceutical companies in additional therapeutic areas, including metabolic disorders and cardiovascular disease. The company was incorporated in 2003 and is headquartered in La Jolla, CA.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AMAM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

AMAM is good value based on its earnings relative to its share price (0.27x), compared to the US market average (15.09x)
P/E vs Market Valuation
AMAM is good value based on its earnings relative to its share price (0.27x), compared to the US Biotechnology industry average (10.7x)
P/E vs Industry Valuation
AMAM is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
There are 30 more AMAM due diligence checks available for Premium users.

Be the first to know about important AMAM news, forecast changes, insider trades & much more!

AMAM News

Valuation

AMAM price to earnings (PE)

For valuing profitable companies with steady earnings
Company
0.27x
Industry
10.7x
Market
15.09x
AMAM is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
AMAM is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

AMAM price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.49x
Industry
5.11x
AMAM is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

AMAM's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
AMAM's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
AMAM's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$180.9M
Liabilities
$39.0M
Debt to equity
0.28
AMAM's short-term assets ($121.01M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AMAM's short-term assets ($121.01M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AMAM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
AMAM's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

AMAM vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
AMAM$69.58M-2.70%0.27x0.49x
APTO$69.77M+2.16%-1.24x1.49x
ADVM$69.81M+0.14%-0.45x0.34x
GLTO$69.32M+8.84%-1.12x0.95x
CADL$69.92M+3.42%60.50x1.34x

Ambrx Biopharma Stock FAQ

What is Ambrx Biopharma's quote symbol?

NYSE: AMAM) Ambrx Biopharma trades on the NYSE under the ticker symbol AMAM. Ambrx Biopharma stock quotes can also be displayed as NYSE: AMAM.

If you're new to stock investing, here's how to buy Ambrx Biopharma stock.

What is the 52 week high and low for Ambrx Biopharma (NYSE: AMAM)?

(NYSE: AMAM) Ambrx Biopharma's 52-week high was $5.12, and its 52-week low was $0.38. It is currently -64.84% from its 52-week high and 373.68% from its 52-week low.

How much is Ambrx Biopharma stock worth today?

(NYSE: AMAM) Ambrx Biopharma currently has 270,328,483 outstanding shares. With Ambrx Biopharma stock trading at $1.80 per share, the total value of Ambrx Biopharma stock (market capitalization) is $69.58M.

Ambrx Biopharma stock was originally listed at a price of $17.05 in Jun 18, 2021. If you had invested in Ambrx Biopharma stock at $17.05, your return over the last 1 years would have been -89.44%, for an annualized return of -89.44% (not including any dividends or dividend reinvestments).

How much is Ambrx Biopharma's stock price per share?

(NYSE: AMAM) Ambrx Biopharma stock price per share is $1.80 today (as of Feb 3, 2023).

What is Ambrx Biopharma's Market Cap?

(NYSE: AMAM) Ambrx Biopharma's market cap is $69.58M, as of Feb 6, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Ambrx Biopharma's market cap is calculated by multiplying AMAM's current stock price of $1.80 by AMAM's total outstanding shares of 270,328,483.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.